CompletedNot Applicable

Effect of Kinesio Taping and Extracorporeal Shock Wave Therapy on Plantar Fasciitis

Turkey (Türkiye)90 participantsStarted 2023-10-02

Plain-language summary

Type of this study: Prospective randomized controlled study. Purpose: The aim of this study is to compare the acute effect of pain level, lower extremity functionality level and plantar fascia flexibility in patients with plantar fasciitis receiving Exportacorporeal Shock Therapy (ESWT). To compare the acute effect of pain level, lower extremity functionality level and plantar fascia flexibility in patients with plantar fasciitis who received KT application in addition to ESWT treatment. To compare the acute effect of pain level, lower extremity functionality level and plantar fascia flexibility in patients with plantar fasciitis receiving placebo application. 90 volunteers will be included in the study as ESWT (n=30), placebo ESWT (n=30), ESWT and KT (n=30) application groups. How effective is ESWT, ESWT and Kinesiotape versus placebo ESWT acutely in the treatment of plantar fasciitis?

Who can participate

Age range

18 Years – 65 Years

Sex

MALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult cases aged 18-65 years diagnosed with plantar fasciitis by a physical medicine and rehabilitation specialist, * Cases willing to continue the study, * In the anamnesis, cases with severe pain when taking the first step after waking up in the morning or after a long period of inactivity and progressive aggravation of the pain as the activity continues, * Cases whose consent forms were obtained by being informed about the study. Exclusion Criteria: * Cases who have undergone foot and ankle surgery, * Loss or decrease of sensation in the foot and ankle region for various reasons, * Difficulty in communication that prevents treatment and evaluations from being carried out effectively, * Pregnancy, * Presence of local infection, * Having a widespread or regional tumoral disease, * Having circulatory disorders in the lower extremities, bleeding, * Anticoagulant use, * Application of other treatment methods such as cold/hot application, exercise, orthosis use, electrotherapy agents, * Cases with a history of systemic, inflammatory, neurological or vascular disease.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Visual Analogue Scale (VAS)

Timeframe: baseline, post treatment (at 1th week)

Trial details

NCT IDNCT06055933

SponsorNecmettin Erbakan University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-10-09

View on ClinicalTrials.gov More Plantar Fasciitis trials